Global Omega 3 (EPA/DHA) Ingredients Market Overview

The Global Omega 3 (EPA/DHA) Ingredients market was valued at USD 1.65 billion in 2023 and is expected to reach USD 2.23 billion by the year 2032, at a CAGR of 3.4%.

Omega-3 (EPA/DHA) ingredients are essential fatty acids that play a critical role in promoting heart health, cognitive function, and reducing inflammation. These ingredients are primarily sourced from marine-based products such as fish oil, krill oil, and algae, with fish oil being the most dominant source. As awareness of the health benefits of omega-3 increases, there has been a growing demand for EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) in dietary supplements, functional foods, pharmaceuticals, and infant formulas. These ingredients are recognized for their efficacy in preventing cardiovascular diseases, supporting brain development in infants, and offering anti-inflammatory properties.

The market for omega-3 EPA/DHA ingredients has seen significant expansion due to the rise in nutraceuticals and functional food consumption. Additionally, the use of sustainable alternatives such as algal oil has gained traction due to concerns over overfishing and environmental sustainability. Leading companies such as DSM, BASF, and Cargill are investing in innovative extraction and production methods to cater to the rising demand for plant-based and pharmaceutical-grade omega-3 products. However, challenges like contamination in fish oil and the cost of production remain as obstacles that need to be addressed for continued growth.

Market Dynamics and Factor for the Omega 3 (EPA/DHA) Ingredients Market:

Drivers:

The market knowledge is being dominantly driven by the growing demand for infant formula products in emerging regions. China is the world's largest consumer of infant formula products, owing to the high birth rate in the country. DHA and EPA are important for infant brain development and immunity strength. DHA has well-established legal strains for inclusion into infant formula products in various regulations and WHO recommendations. Infant formula gains the key market share for algae omega-3 consumer products in China.

Based on a Norwegian study, omega-3 demonstrates a positive effect on a child's brain and improves a child's problem-solving abilities. According to recent research studies, high doses of DHA in baby formula or breast milk can have a worthwhile effect on the growth of preterm infants, such as growth in height. In some economies, such as China, where both the adult population and infant population are on the rise, the demand for infant nutrition and baby food is constantly increasing. The demand for infant nutrition fortified with omega-3 is rising from the parents who have busy lifestyles and less time to prepare meals.

Restraints:

Omega-3 levels can be raised through diet, but the easiest way to ensure constant and adequate intake is through daily dietary supplementation. Even though health-conscious consumers and heart condition patients understand the comfort of upping their omega-3 intake, a recent study by Euromonitor examined economies such as the US, United Kingdom (UK) and China, and found that most individuals were not getting enough of the daily recommended amount of Omega-3 fatty acids.

Opportunities:

As dietary supplement forms an active part of the daily diet in modernizing lifestyle, it is anticipated that there will be greater demand for the Omega 3 ingredients across the world. Key developers and manufacturers are showing keen interest in Omega 3 ingredients, as the global dietary supplements market is demanding, hence it can be expected that there would be greater market opportunities and higher returns for the investors in the EPA/DHA (Omega 3) Ingredients Market. Omega 3 ingredients have been supporting both physical and mental health, so it is used as both dietary supplement and preventive medicine which supply lucrative opportunities for the producers over the globe.

Market Segmentation

Segmentation Analysis of Omega 3 (EPA/DHA) Ingredients Market:

Based on the Type, the market is classified into eicosatetraenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). The combination of DHA and EPA helps in decreasing bad cholesterol and coronary heart diseases, such as strokes and blood pressure, which is expected to accelerate the growth of these segments.
Based on the Application, dietary supplements dominated the industry during the forecast period owing to the different health benefits of omega 3, growing R&D initiatives, and rising healthcare costs. Increasing the utilization of dietary supplements to maintain fitness and nutrient adequacy among adults is projected to increase the consumption of omega 3 in dietary supplement products. Dietary supplements are primarily consumed to ensure the intake of nutritional constituents important for the human body. Growing experiences of cardiovascular diseases due to the inactive and slow lifestyle, primarily among the age group of 30 to 40 years, and changing dietary patterns are the factors projected to hasten the importance of omega 3-based nutraceutical products in the market during the forecast period.
Based on the Source, fish oil and krill oil of marine source of omega 3 fatty acids accounted maximum share and is expected to witness significant growth during the forecast period. Demand for marine-based products is driven by rising consumer interest in omega 3 fatty acids obtained from fish and krill oils. Growing consumption of omega 3 in the form of fortified food products, such as fish ham and fish sausages, is expected to drive the segment in the upcoming years. Furthermore, rising awareness about the consumption of high triglyceride levels is anticipated to stimulate the demand for omega 3-fortified foods.

Regional Analysis of Omega 3 (EPA/DHA) Ingredients Market:

Omega 3 ingredients are mainly obtained and processed in North America, owing to increasing dietary supplement brands and massive herbal and chemical processing companies. In the US, consumers show an extensive interest in Omega 3 ingredients owing to inflating neurological disorders.
In Europe, Omega 3 ingredients have diverse supply chains and wider applications owing to rising concern for cognitive health and cancer prevention.  Growing product utilization, primarily in the form of dietary supplements, on account of the rising aging population in emerged economies, such as the Netherlands, Germany, France, and the U.K., is probably to turn the market.
In the Asia Pacific region, Omega 3 ingredients are used as herbal recoveries owing to traditional medical practices and as an oil, it is used in regions of Australia, China, etc. Growing intake of fish oil in the daily diet, as well as rising health consciousness, are increasing the demand for omega 3 in this region. Furthermore, the increasing cultivation of krill fish in the South China Sea and the Indian Ocean is anticipated to accelerate the regional market growth during the forecast period.
In the Middle East & Africa, Omega 3 ingredients are imported for emerging mental health with lesser utilizations. Owing to growing demands and distributions, the growth of the global Omega 3 ingredients market is anticipated to remain positive in the projected period. In Latin America, EPA/DHA (Omega 3) Ingredients are mostly consumed as preventive medicine for cardiovascular diseases owing to raised health consciousness.

Players Covered in Omega 3 (EPA/DHA) Ingredients Market are:

• BASF SE (Germany)
• DSM (Netherlands)
• Aker BioMarine ASA (Norway)
• Croda International PLC (UK)
• Stepan Company (US)
• Pharma Marine (Norway)
• GC Riber Group (Norway)
• Clover Corporation (Australia)
• Omega Protein Corporation (US)
• Cellana (US)
• United Laboratories (India)
• Abee (India)
• Ocean Nutrition Canada Limited (Canada)
• Arista Industries (US) and other major players.

Key Industry Development for the Omega 3 (EPA/DHA) Ingredients Market:

• In September 2024, the Global Organization for EPA and DHA Omega-3s (GOED) highlighted modest growth in the omega-3 ingredient market, with global volume reaching 124,480 metric tons in 2023, a 1.4% rise from 2022. Despite supply shortages and price increases, demand for dietary supplements remained stable, while pet nutrition, especially in China and the U.S., experienced significant expansion. High-value sectors like pharmaceuticals and infant formula also contributed to the market's overall progress.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Source
 3.3 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Omega 3 (EPA/DHA) Ingredients Market by Type
 5.1 Omega 3 (EPA/DHA) Ingredients Market Overview Snapshot and Growth Engine
 5.2 Omega 3 (EPA/DHA) Ingredients Market Overview
 5.3 Alpha-Linolenic Acid {ALA}
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Alpha-Linolenic Acid {ALA}: Grographic Segmentation
 5.4 Eicosapentaenoic Acid {EPA}
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Eicosapentaenoic Acid {EPA}: Grographic Segmentation
 5.5 Docosahexaenoic Acid {DHA}
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Docosahexaenoic Acid {DHA}: Grographic Segmentation

Chapter 6: Omega 3 (EPA/DHA) Ingredients Market by Source
 6.1 Omega 3 (EPA/DHA) Ingredients Market Overview Snapshot and Growth Engine
 6.2 Omega 3 (EPA/DHA) Ingredients Market Overview
 6.3 Fish Oil & Krill Oil
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Fish Oil & Krill Oil: Grographic Segmentation
 6.4 Algal Oil
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Algal Oil: Grographic Segmentation
 6.5 Walnut
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Walnut: Grographic Segmentation
 6.6 Pumpkin Seeds
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Pumpkin Seeds: Grographic Segmentation
 6.7 Soyabean Oil
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Soyabean Oil: Grographic Segmentation
 6.8 Others
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size (2017-2032F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Others: Grographic Segmentation

Chapter 7: Omega 3 (EPA/DHA) Ingredients Market by Application
 7.1 Omega 3 (EPA/DHA) Ingredients Market Overview Snapshot and Growth Engine
 7.2 Omega 3 (EPA/DHA) Ingredients Market Overview
 7.3 Pharmaceutical Industry
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Pharmaceutical Industry: Grographic Segmentation
 7.4 Dietary Supplement
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Dietary Supplement: Grographic Segmentation
 7.5 Food & Beverage Industry
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Food & Beverage Industry: Grographic Segmentation
 7.6 Animal Nutrition
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Animal Nutrition: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Omega 3 (EPA/DHA) Ingredients Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Omega 3 (EPA/DHA) Ingredients Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Omega 3 (EPA/DHA) Ingredients Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 BASF SE
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 DSM
 8.4 AKER BIOMARINE ASA
 8.5 CRODA INTERNATIONAL PLC
 8.6 STEPAN COMPANY
 8.7 PHARMA MARINE
 8.8 GC RIBER GROUP
 8.9 CLOVER CORPORATION
 8.10 OMEGA PROTEIN CORPORATION
 8.11 CELLANA
 8.12 UNITED LABORATORIES
 8.13 ABEE
 8.14 OCEAN NUTRITION CANADA LIMITED
 8.15 ARISTA INDUSTRIES
 8.16 OTHER MAJOR PLAYERS

Chapter 9: Global Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Alpha-Linolenic Acid {ALA}
  9.2.2 Eicosapentaenoic Acid {EPA}
  9.2.3 Docosahexaenoic Acid {DHA}
 9.3 Historic and Forecasted Market Size By Source
  9.3.1 Fish Oil & Krill Oil
  9.3.2 Algal Oil
  9.3.3 Walnut
  9.3.4 Pumpkin Seeds
  9.3.5 Soyabean Oil
  9.3.6 Others
 9.4 Historic and Forecasted Market Size By Application
  9.4.1 Pharmaceutical Industry
  9.4.2 Dietary Supplement
  9.4.3 Food & Beverage Industry
  9.4.4 Animal Nutrition

Chapter 10: North America Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Alpha-Linolenic Acid {ALA}
  10.4.2 Eicosapentaenoic Acid {EPA}
  10.4.3 Docosahexaenoic Acid {DHA}
 10.5 Historic and Forecasted Market Size By Source
  10.5.1 Fish Oil & Krill Oil
  10.5.2 Algal Oil
  10.5.3 Walnut
  10.5.4 Pumpkin Seeds
  10.5.5 Soyabean Oil
  10.5.6 Others
 10.6 Historic and Forecasted Market Size By Application
  10.6.1 Pharmaceutical Industry
  10.6.2 Dietary Supplement
  10.6.3 Food & Beverage Industry
  10.6.4 Animal Nutrition
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Alpha-Linolenic Acid {ALA}
  11.4.2 Eicosapentaenoic Acid {EPA}
  11.4.3 Docosahexaenoic Acid {DHA}
 11.5 Historic and Forecasted Market Size By Source
  11.5.1 Fish Oil & Krill Oil
  11.5.2 Algal Oil
  11.5.3 Walnut
  11.5.4 Pumpkin Seeds
  11.5.5 Soyabean Oil
  11.5.6 Others
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Pharmaceutical Industry
  11.6.2 Dietary Supplement
  11.6.3 Food & Beverage Industry
  11.6.4 Animal Nutrition
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Alpha-Linolenic Acid {ALA}
  12.4.2 Eicosapentaenoic Acid {EPA}
  12.4.3 Docosahexaenoic Acid {DHA}
 12.5 Historic and Forecasted Market Size By Source
  12.5.1 Fish Oil & Krill Oil
  12.5.2 Algal Oil
  12.5.3 Walnut
  12.5.4 Pumpkin Seeds
  12.5.5 Soyabean Oil
  12.5.6 Others
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Pharmaceutical Industry
  12.6.2 Dietary Supplement
  12.6.3 Food & Beverage Industry
  12.6.4 Animal Nutrition
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Alpha-Linolenic Acid {ALA}
  13.4.2 Eicosapentaenoic Acid {EPA}
  13.4.3 Docosahexaenoic Acid {DHA}
 13.5 Historic and Forecasted Market Size By Source
  13.5.1 Fish Oil & Krill Oil
  13.5.2 Algal Oil
  13.5.3 Walnut
  13.5.4 Pumpkin Seeds
  13.5.5 Soyabean Oil
  13.5.6 Others
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Pharmaceutical Industry
  13.6.2 Dietary Supplement
  13.6.3 Food & Beverage Industry
  13.6.4 Animal Nutrition
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Omega 3 (EPA/DHA) Ingredients Market Analysis, Insights and Forecast, 2017-2032
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Alpha-Linolenic Acid {ALA}
  14.4.2 Eicosapentaenoic Acid {EPA}
  14.4.3 Docosahexaenoic Acid {DHA}
 14.5 Historic and Forecasted Market Size By Source
  14.5.1 Fish Oil & Krill Oil
  14.5.2 Algal Oil
  14.5.3 Walnut
  14.5.4 Pumpkin Seeds
  14.5.5 Soyabean Oil
  14.5.6 Others
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Pharmaceutical Industry
  14.6.2 Dietary Supplement
  14.6.3 Food & Beverage Industry
  14.6.4 Animal Nutrition
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET COMPETITIVE RIVALRY
TABLE 005. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET THREAT OF SUBSTITUTES
TABLE 007. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET BY TYPE
TABLE 008. ALPHA-LINOLENIC ACID {ALA} MARKET OVERVIEW (2016-2028)
TABLE 009. EICOSAPENTAENOIC ACID {EPA} MARKET OVERVIEW (2016-2028)
TABLE 010. DOCOSAHEXAENOIC ACID {DHA} MARKET OVERVIEW (2016-2028)
TABLE 011. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET BY SOURCE
TABLE 012. FISH OIL & KRILL OIL MARKET OVERVIEW (2016-2028)
TABLE 013. ALGAL OIL MARKET OVERVIEW (2016-2028)
TABLE 014. WALNUT MARKET OVERVIEW (2016-2028)
TABLE 015. PUMPKIN SEEDS MARKET OVERVIEW (2016-2028)
TABLE 016. SOYABEAN OIL MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET BY APPLICATION
TABLE 019. PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 020. DIETARY SUPPLEMENT MARKET OVERVIEW (2016-2028)
TABLE 021. FOOD & BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 022. ANIMAL NUTRITION MARKET OVERVIEW (2016-2028)
TABLE 023. NORTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 024. NORTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 025. NORTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 026. N OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 029. EUROPE OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 030. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 031. ASIA PACIFIC OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 032. ASIA PACIFIC OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 033. ASIA PACIFIC OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 034. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 038. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 039. SOUTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 040. SOUTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 041. SOUTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 042. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 043. BASF SE: SNAPSHOT
TABLE 044. BASF SE: BUSINESS PERFORMANCE
TABLE 045. BASF SE: PRODUCT PORTFOLIO
TABLE 046. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. DSM: SNAPSHOT
TABLE 047. DSM: BUSINESS PERFORMANCE
TABLE 048. DSM: PRODUCT PORTFOLIO
TABLE 049. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. AKER BIOMARINE ASA: SNAPSHOT
TABLE 050. AKER BIOMARINE ASA: BUSINESS PERFORMANCE
TABLE 051. AKER BIOMARINE ASA: PRODUCT PORTFOLIO
TABLE 052. AKER BIOMARINE ASA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. CRODA INTERNATIONAL PLC: SNAPSHOT
TABLE 053. CRODA INTERNATIONAL PLC: BUSINESS PERFORMANCE
TABLE 054. CRODA INTERNATIONAL PLC: PRODUCT PORTFOLIO
TABLE 055. CRODA INTERNATIONAL PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. STEPAN COMPANY: SNAPSHOT
TABLE 056. STEPAN COMPANY: BUSINESS PERFORMANCE
TABLE 057. STEPAN COMPANY: PRODUCT PORTFOLIO
TABLE 058. STEPAN COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. PHARMA MARINE: SNAPSHOT
TABLE 059. PHARMA MARINE: BUSINESS PERFORMANCE
TABLE 060. PHARMA MARINE: PRODUCT PORTFOLIO
TABLE 061. PHARMA MARINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. GC RIBER GROUP: SNAPSHOT
TABLE 062. GC RIBER GROUP: BUSINESS PERFORMANCE
TABLE 063. GC RIBER GROUP: PRODUCT PORTFOLIO
TABLE 064. GC RIBER GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. CLOVER CORPORATION: SNAPSHOT
TABLE 065. CLOVER CORPORATION: BUSINESS PERFORMANCE
TABLE 066. CLOVER CORPORATION: PRODUCT PORTFOLIO
TABLE 067. CLOVER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. OMEGA PROTEIN CORPORATION: SNAPSHOT
TABLE 068. OMEGA PROTEIN CORPORATION: BUSINESS PERFORMANCE
TABLE 069. OMEGA PROTEIN CORPORATION: PRODUCT PORTFOLIO
TABLE 070. OMEGA PROTEIN CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. CELLANA: SNAPSHOT
TABLE 071. CELLANA: BUSINESS PERFORMANCE
TABLE 072. CELLANA: PRODUCT PORTFOLIO
TABLE 073. CELLANA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. UNITED LABORATORIES: SNAPSHOT
TABLE 074. UNITED LABORATORIES: BUSINESS PERFORMANCE
TABLE 075. UNITED LABORATORIES: PRODUCT PORTFOLIO
TABLE 076. UNITED LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ABEE: SNAPSHOT
TABLE 077. ABEE: BUSINESS PERFORMANCE
TABLE 078. ABEE: PRODUCT PORTFOLIO
TABLE 079. ABEE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. OCEAN NUTRITION CANADA LIMITED: SNAPSHOT
TABLE 080. OCEAN NUTRITION CANADA LIMITED: BUSINESS PERFORMANCE
TABLE 081. OCEAN NUTRITION CANADA LIMITED: PRODUCT PORTFOLIO
TABLE 082. OCEAN NUTRITION CANADA LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. ARISTA INDUSTRIES: SNAPSHOT
TABLE 083. ARISTA INDUSTRIES: BUSINESS PERFORMANCE
TABLE 084. ARISTA INDUSTRIES: PRODUCT PORTFOLIO
TABLE 085. ARISTA INDUSTRIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 086. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 087. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 088. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY TYPE
FIGURE 012. ALPHA-LINOLENIC ACID {ALA} MARKET OVERVIEW (2016-2028)
FIGURE 013. EICOSAPENTAENOIC ACID {EPA} MARKET OVERVIEW (2016-2028)
FIGURE 014. DOCOSAHEXAENOIC ACID {DHA} MARKET OVERVIEW (2016-2028)
FIGURE 015. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY SOURCE
FIGURE 016. FISH OIL & KRILL OIL MARKET OVERVIEW (2016-2028)
FIGURE 017. ALGAL OIL MARKET OVERVIEW (2016-2028)
FIGURE 018. WALNUT MARKET OVERVIEW (2016-2028)
FIGURE 019. PUMPKIN SEEDS MARKET OVERVIEW (2016-2028)
FIGURE 020. SOYABEAN OIL MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY APPLICATION
FIGURE 023. PHARMACEUTICAL INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 024. DIETARY SUPPLEMENT MARKET OVERVIEW (2016-2028)
FIGURE 025. FOOD & BEVERAGE INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 026. ANIMAL NUTRITION MARKET OVERVIEW (2016-2028)
FIGURE 027. NORTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. EUROPE OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. ASIA PACIFIC OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. MIDDLE EAST & AFRICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. SOUTH AMERICA OMEGA 3 (EPA/DHA) INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)